Identification and quantification of osteopontin splice variants in the plasma of lung cancer patients using immunoaffinity capture and targeted mass spectrometry

Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer

(2011) Bai Zhao et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Targeted mass spectrometry approaches for protein biomarker verification

(2011) Zhaojing Meng et al.   Journal of Proteomics

Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma—Which is best?

(2011) Jenette Creaney et al.   LUNG CANCER

Osteopontin-c Splicing Isoform Contributes to Ovarian Cancer Progression

(2011) T. M. Tilli et al.   MOLECULAR CANCER RESEARCH

Quantitative Mass Spectrometry Evaluation of Human Retinol Binding Protein 4 and Related Variants

(2011) Urban A. Kiernan et al.   PLoS One

An immunoaffinity liquid chromatography–tandem mass spectrometry assay for the quantitation of matrix metalloproteinase 9 in mouse serum

(2010) Mireia Fernández Ocaña et al.   ANALYTICAL BIOCHEMISTRY

An Approach to Quantifying N-Linked Glycoproteins by Enzyme-Catalyzed18O3-Labeling of Solid-Phase Enriched Glycopeptides

(2010) Quazi Shakey et al.   ANALYTICAL CHEMISTRY

Reduction of Elevated Plasma Osteopontin Levels With Resection of Non–Small-Cell Lung Cancer

(2010) Justin D. Blasberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Functional Heterogeneity of Osteopontin Isoforms in Non-small Cell Lung Cancer

(2010) Chandra M.V. Goparaju et al.   Journal of Thoracic Oncology

The RGD Domain of Human Osteopontin Promotes Tumor Growth and Metastasis through Activation of Survival Pathways

(2010) Donald Courter et al.   PLoS One

Tumorigenic properties of alternative osteopontin isoforms in mesothelioma

(2009) Sergey V. Ivanov et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The Bottleneck in the Cancer Biomarker Pipeline and Protein Quantification through Mass Spectrometry-Based Approaches: Current Strategies for Candidate Verification

(2009) S. Makawita et al.   CLINICAL CHEMISTRY

New Dual Monoclonal ELISA for Measuring Plasma Osteopontin as a Biomarker Associated with Survival in Prostate Cancer: Clinical Validation and Comparison of Multiple ELISAs

(2009) P. H. Anborgh et al.   CLINICAL CHEMISTRY

Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry

(2009) E. Kuhn et al.   CLINICAL CHEMISTRY

Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity

(2009) Justin D. Blasberg et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma

(2009) Jennifer Sullivan et al.   SURGERY

Post-translational modification and proteolytic processing of urinary osteopontin

(2008) Brian Christensen et al.   BIOCHEMICAL JOURNAL

Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer

(2008) Alicia Plumer et al.   BMC CANCER

Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003

(2008) Philip C. Mack et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of an Immunoaffinity-Mass Spectrometry-based Approach for the Quantification of Protein Biomarkers from Serum Samples of Lung Cancer Patients

(2008) Gordon R. Nicol et al.   MOLECULAR & CELLULAR PROTEOMICS

Interaction of osteopontin with neutrophil α4β1 and α9β1 integrins in a rodent model of alcoholic liver disease

(2008) Atrayee Banerjee et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Osteopontin-c is a selective marker of breast cancer

(2007) Mana Mirza et al.   INTERNATIONAL JOURNAL OF CANCER